Sonendo Inc
NYSE:SONX
Intrinsic Value
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. [ Read More ]
The intrinsic value of one SONX stock under the Base Case scenario is 1.6206 USD. Compared to the current market price of 0.1059 USD, Sonendo Inc is Undervalued by 93%.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Sonendo Inc's business.
What risks and challenges
does Sonendo Inc face in the near future?
Summarize the latest earnings report
of Sonendo Inc.
Provide P/E
for Sonendo Inc and its competitors.
Balance Sheet Decomposition
Sonendo Inc
Current Assets | 75.5m |
Cash & Short-Term Investments | 55.9m |
Receivables | 5.6m |
Other Current Assets | 14m |
Non-Current Assets | 12.8m |
PP&E | 3.5m |
Intangibles | 9.2m |
Other Non-Current Assets | 100k |
Current Liabilities | 11.1m |
Accounts Payable | 1m |
Accrued Liabilities | 8.3m |
Other Current Liabilities | 1.8m |
Non-Current Liabilities | 39.4m |
Long-Term Debt | 37.2m |
Other Non-Current Liabilities | 2.2m |
Earnings Waterfall
Sonendo Inc
Revenue
|
44.4m
USD
|
Cost of Revenue
|
-32.8m
USD
|
Gross Profit
|
11.6m
USD
|
Operating Expenses
|
-70.8m
USD
|
Operating Income
|
-59.2m
USD
|
Other Expenses
|
-1.7m
USD
|
Net Income
|
-60.9m
USD
|
Free Cash Flow Analysis
Sonendo Inc
What is Free Cash Flow?
SONX Profitability Score
Profitability Due Diligence
Sonendo Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Sonendo Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
SONX Solvency Score
Solvency Due Diligence
Sonendo Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Sonendo Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SONX Price Targets Summary
Sonendo Inc
According to Wall Street analysts, the average 1-year price target for SONX is 0.25 USD .
Ownership
SONX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SONX Price
Sonendo Inc
Average Annual Return | -56.36% |
Standard Deviation of Annual Returns | 6.52% |
Max Drawdown | -100% |
Market Capitalization | 6.7m USD |
Shares Outstanding | 63 547 467 |
Percentage of Shares Shorted | 0.92% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 219 full-time employees. The company went IPO on 2021-10-29. The firm has developed GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company is focused on leveraging the GentleWave System, a root canal therapy for late-stage tooth decay that employs a sterilized, single-use procedure instrument. In addition to its GentleWave console and single-use procedure instruments, it also offers single-use products, such as SoundSeal and the Company's Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown. Its EDTA is a liquid used during the GentleWave Procedure to help debride and disinfect the root canal system. The company also offers TDO practice management software.